1. van Thiel GJ, van Delden JJ: Phase IV research: innovation in need of ethics. J Med Ethics. 2008 June, 34 (6): 415-416. 10.1136/jme.2007.023911.
2. CMR International Institute for Regulatory Science: New development paradigms: building regulatory confidence for the early release of medicines. 2010, Available at
http://cirsci.org/system/files/private/1023_October2010_Workshop.pdf
3. Boessen R: PhD dissertation, Utrecht University, 2013. Methods to improve the efficiency of confirmatory clinical trials. Available at
http://igitur-archive.library.uu.nl/dissertations/2013-0501-200840/UUindex.html
4. PriceWaterhouseCoopers: Pharma 2020: the vision. 2007, Available at
http://www.pwc.com/gx/en/pharma-life-sciences/pharma-2020/pharma-2020-vision-path.jhtml
5. Mello MM, Goodman SN, Faden RR: Ethical considerations in studying drug safety–the institute of medicine report. N Engl J Med. 2012 September 6, 367 (10): 959-964. 10.1056/NEJMhle1207160.